Michael Cuffe Sells 3,836 Shares of HCA Healthcare (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

HCA Healthcare Price Performance

NYSE:HCA opened at $413.63 on Wednesday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $420.98. The stock has a market cap of $96.78 billion, a P/E ratio of 17.39, a PEG ratio of 1.31 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company has a fifty day moving average price of $381.31 and a 200 day moving average price of $361.47.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter in the prior year, the company posted $5.50 EPS. The business’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Institutional Investors Weigh In On HCA Healthcare

A number of hedge funds have recently added to or reduced their stakes in HCA. Norges Bank bought a new stake in HCA Healthcare during the 2nd quarter worth about $1,152,408,000. GAMMA Investing LLC lifted its position in HCA Healthcare by 40,527.3% during the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. Nuveen LLC acquired a new position in HCA Healthcare during the 1st quarter valued at about $569,217,000. Pacer Advisors Inc. lifted its position in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of a number of recent research reports. Cantor Fitzgerald restated an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday, August 26th. Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Bank of America lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 target price on the stock. in a report on Wednesday, July 16th. Finally, Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.